Validation of C-Reactive protein and CURB-65 in the first hospital admission community acquired-pneumonia patient  as a predictor of 30 days mortality

B. Foresto Buharman (Jakarta, Indonesia)

Source: International Congress 2018 – Improving the outcomes of community-acquired pneumonia
Session: Improving the outcomes of community-acquired pneumonia
Session type: Poster Discussion
Number: 2041
Disease area: Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
B. Foresto Buharman (Jakarta, Indonesia). Validation of C-Reactive protein and CURB-65 in the first hospital admission community acquired-pneumonia patient  as a predictor of 30 days mortality. 2041

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Scores of community acquired pneumonia for predicting intensive care admission and mortality
Source: Respiratory Failure and Mechanical Ventilation Conference 2020
Year: 2020



Assessment of prognostic scores for 30-day mortality prediction in hospitalised patients with health care associated pneumonia (HCAP)
Source: Annual Congress 2010 - The prognosis of community-acquired pneumonia: old and new markers of severity
Year: 2010

C-reactive protein as a predictor of mortality in patients with severe sepsis in intensive care unit
Source: Annual Congress 2011 - Mechanical ventilation and lung injury: new advances
Year: 2011


Community acquired pneumonia in the emergency department: Comparison of clinical indication to in-hospital treatment and severity scales predicting mortality
Source: Annual Congress 2012 - Respiratory infections: prognosis and outcome
Year: 2012

Risk factors of ICU admission and death among hospitalized patients with Influenza(H1N1)
Source: Annual Congress 2010 - Influenza A (H1N1): characteristics, risk factors and prognosis
Year: 2010

Galectin-3 as predictor of mortality and ICU admission in patients with COVID 19 Acute Respiratory Failure
Source: Virtual Congress 2021 – Severe acute respiratory failure
Year: 2021



Mortality after hospitalisation for COVID19, and identification of prognostic factors on admission that increase mortality risk
Source: Virtual Congress 2021 – COVID - 19
Year: 2021


CURB-65 scoring utilization in predicting mortality of hospitalized patients with AE-COPD
Source: Annual Congress 2012 - Diagnostic insights and decision making in primary care
Year: 2012


Admission clinical parameters in predicting in-hospital mortality in COVID-19
Source: Virtual Congress 2021 – COVID - 19 biomarkers
Year: 2021


Changes in SPPB during hospital admission for AECOPD
Source: Virtual Congress 2020 – Comprehensive care and pulmonary rehabilitation for chronic respiratory diseases
Year: 2020


Comparison of prospective scores for predicting mortality and hospital admission in hospitalised patients and out-patients with CAP
Source: Annual Congress 2005 - Community-acquired pneumonia: clinical approaches
Year: 2005


Determining the prognostic value of procalcitonin in ICU patients who developed hospital acquired pneumonia and comparing with sencitive CRP
Source: Annual Congress 2009 - Impact of biomarkers in the management of community-acquired pneumonia
Year: 2009


Pro-adrenomedullin, procalcitonin and CRP levels to predict bacterial pneumonia in patients admitted to emergency room
Source: Annual Congress 2011 - Biomarkers and outcomes of community-acquired pneumonia
Year: 2011

Evaluation of DECAF, CURB-65 and BAP-65 scales as predictor of mortality risk in acute exacerbation of COPD in a retrospective cohort
Source: International Congress 2017 – Primary care diagnosis, assessment and management of COPD
Year: 2017

Studying the association between mortality in patients requiring hospital admission for Community Acquired Pneumonia and pre-hospital antibiotic treatment in primary care
Source: International Congress 2017 – Discussion of vaccines, biomarkers and risk factors analysis  
Year: 2017

Performance of CURB-65 and eCURB severity assessment for health care associated pneumonia in an emergency department
Source: Annual Congress 2010 - The prognosis of community-acquired pneumonia: old and new markers of severity
Year: 2010


Does TISS-28 predict the outcome of ICU patients in our respiratory care unit?
Source: Annual Congress 2010 - Intensive care unit outcome
Year: 2010

EABPCO-CPHG study: Prognosis factors of death and/or hospital admission in 1,142 patients, at 3 months after their admission to the pneumology department of a French general hospital for COPD acute exacerbation (AE)
Source: Annual Congress 2010 - COPD exacerbation
Year: 2010


CAB score predicts short-term mortality at hospital admission for acute exacerbations of COPD
Source: International Congress 2017 – COPD management: new findings from large studies
Year: 2017



Mortality predictions of CURB-65, GPS and CALL scores in hospitalized patients with COVID-19
Source: Virtual Congress 2021 – COVID - 19 risk predictions
Year: 2021